Quantcast

Latest Tarenflurbil Stories

36282_web
2011-09-25 15:24:40

Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.

2009-12-16 00:16:33

Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.

2008-10-03 12:00:05

Eli Lilly and Company has announced that it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.

2008-09-18 09:00:11

By Lois M. Collins Deseret News Researchers at the University of Utah are looking for volunteers who have mild to moderate Alzheimer's disease to test a drug that may slow its associated decline.

2008-07-31 12:00:23

U.S. medical scientists say a drug commonly prescribed to treat immunodeficiencies has shown promise as a treatment for Alzheimer's disease.

2008-07-31 06:00:00

By Jeremy Manier, Chicago Tribune Jul. 31--Editor's note: Due to a production error, this story from Wednesday's newspaper did not run in full. This is the complete text.

f9d530ba7c3661f35d662e695f3f33731
2008-07-30 16:34:03

An experimental Alzheimer’s drug shows promise in halting progression of the disease through a new approach of dissolving the protein tangles that form in victims’ brain.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.